Clinical Trial Update: SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SPY-X for sentinel node localization in melanoma and breast cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma

Drugs mentioned

• SPY-X

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Sentinel Lymph Node, Melanoma (Skin) | Phase 3 | Status: COMPLETED | Results posted: 2023-01-12